Oxford Cancer Biomarkers

Developer of biomarker diagnostics for cancer therapies

placeOxford, England, United Kingdom calendar_todayFounded 2011 groups12 employees language oxfordbio.com

Registered entities

Innovation

2 patent families (1 granted) — focus: Human necessities, Physics & computing; filing pace accelerating. Cited 67 times.

YearFilings
20151
20161
20171
20181
20191
20211
20221
20242
20251

Investor mix

20 investors on record; lead investors include Plutus Investment Group.

Investor typeCountShare
Venture capital315%
Accelerator & incubator15%
Bank & private debt15%
Other / undisclosed1575%
Coming soon